Los Angeles Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Los Angeles Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,400	Closed	-$584K	–	1721
2021 Q1	$584K	Sell	11,400 -11,485	-50%	-$691K	﹤0.01%	1150
2020 Q4	$1.42M	Buy	22,885 +3,190	+16%	+$183K	0.01%	789
2020 Q3	$1.08M	Buy	19,695 +4,160	+27%	+$224K	0.01%	798
2020 Q2	$894K	Sell	15,535 -150	-1%	-$8.16K	﹤0.01%	888
2020 Q1	$630K	Buy	15,685 +470	+3%	+$20K	﹤0.01%	836
2019 Q4	$602K	Buy	+15,215	New	+$267K	﹤0.01%	973
2019 Q3	–	Sell	-23,692	Closed	-$220K	–	1401
2019 Q2	$220K	Buy	23,692 +1,920	+9%	+$22.2K	﹤0.01%	1273
2019 Q1	$302K	Buy	21,772 +2,740	+14%	+$31.3K	﹤0.01%	1195
2018 Q4	$208K	Sell	19,032 -4,900	-20%	-$51.7K	﹤0.01%	1199
2018 Q3	$303K	Hold	23,932	–	–	﹤0.01%	1222
2018 Q2	$315K	Buy	+23,932	New	+$286K	﹤0.01%	1270
2018 Q1	–	Sell	-90,684	Closed	-$540K	–	1443
2017 Q4	$540K	Buy	90,684 +34,904	+63%	+$239K	﹤0.01%	1031
2017 Q3	$414K	Buy	+55,780	New	+$464K	﹤0.01%	1059

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Los Angeles Capital Management's CCXI Position: Q2 2021 in Review

Los Angeles Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 11,400 shares — an estimated $584K sold.

Los Angeles Capital Management first reported a position in CCXI in Q3 2017 and held it in 13 quarters. The position peaked at $1.42M in Q4 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

Los Angeles Capital Management reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
Los Angeles Capital Management sold 11,400 ChemoCentryx, Inc. shares in Q2 2021, an estimated $584K.
Los Angeles Capital Management first reported a position in ChemoCentryx, Inc. in Q3 2017 and held it in 13 quarters.
Los Angeles Capital Management's ChemoCentryx, Inc. position peaked at $1.42M in Q4 2020.
146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Los Angeles Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.